TRCT
AGN

Tower Research Capital (TRC)’s Allergan plc AGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-400
Closed -$71K – 5180
2020
Q1 		$71K Buy
+400
New +$75.3K ﹤0.01% 1128
2019
Q4 		– Sell
-10,248
Closed -$1.72M – 4820
2019
Q3 		$1.72M Sell
10,248
-8,199
-44% -$1.34M 0.12% 145
2019
Q2 		$3.09M Buy
18,447
+10,960
+146% +$1.52M 0.21% 63
2019
Q1 		$1.1M Sell
7,487
-1,318
-15% -$191K 0.07% 252
2018
Q4 		$1.18M Buy
8,805
+7,123
+423% +$1.17M 0.08% 232
2018
Q3 		$320K Sell
1,682
-7,245
-81% -$1.33M 0.02% 729
2018
Q2 		$1.49M Buy
8,927
+8,727
+4,364% +$1.4M 0.08% 230
2018
Q1 		$34K Sell
200
-1,568
-89% -$263K ﹤0.01% 1906
2017
Q4 		$289K Buy
1,768
+1,463
+480% +$263K 0.04% 447
2017
Q3 		$63K Sell
305
-539
-64% -$125K 0.01% 1772
2017
Q2 		$205K Sell
844
-218
-21% -$51.2K 0.02% 335
2017
Q1 		$253K Sell
1,062
-2,391
-69% -$557K 0.03% 253
2016
Q4 		$725K Buy
3,453
+2,386
+224% +$494K 0.08% 264
2016
Q3 		$246K Sell
1,067
-1,720
-62% -$420K 0.02% 394
2016
Q2 		$644K Buy
+2,787
New +$643K 0.06% 222
2015
Q3 		– Sell
-300
Closed -$91K – 5116
2015
Q2 		$91K Sell
300
-6,046
-95% -$1.8M 0.01% 922
2015
Q1 		$1.89M Buy
6,346
+6,046
+2,015% +$1.72M 0.23% 62
2014
Q4 		$77K Buy
+300
New +$75K 0.01% 830
2014
Q2 		– Sell
-1,327
Closed -$274K – 4881
2014
Q1 		$274K Buy
1,327
+1,127
+564% +$223K 0.04% 327
2013
Q4 		$34K Buy
200
+36
+22% +$5.63K 0.01% 1762
2013
Q3 		$24K Sell
164
-3
-2% -$400 ﹤0.01% 2550
2013
Q2 		$21K Buy
+167
New +$18.9K ﹤0.01% 1673

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Tower Research Capital (TRC)'s AGN Position: Q2 2020 in Review

Tower Research Capital (TRC) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 400 shares — an estimated $71K sold.

Tower Research Capital (TRC) first reported a position in AGN in Q2 2013 and held it in 22 quarters. The position peaked at $3.09M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Tower Research Capital (TRC) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 400 Allergan plc shares in Q2 2020, an estimated $71K.
  • Tower Research Capital (TRC) first reported a position in Allergan plc in Q2 2013 and held it in 22 quarters.
  • Tower Research Capital (TRC)'s Allergan plc position peaked at $3.09M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.